SeraCare Life Sciences (SRLS) Tops Q1 EPS by 1c

May 12, 2011 7:35 AM EDT
SeraCare Life Sciences, Inc. (Nasdaq: SRLS) reported Q1 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $11 million versus the consensus estimate of $11.21 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings